<qa>  What is the name of the patient who receives PDL IV?- Arm I: Patients receive pegylated doxorubicin hydrochloride liposome PDL IV over 1 hour on day 1. Treatment repeats every 2 weeks for 8 courses in the absence of disease progression or unacceptable toxicity. 